BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stout JE, Wu Y, Ho CS, Pettit AC, Feng PJ, Katz DJ, Ghosh S, Venkatappa T, Luo R; Tuberculosis Epidemiologic Studies Consortium. Evaluating latent tuberculosis infection diagnostics using latent class analysis. Thorax 2018;73:1062-70. [PMID: 29982223 DOI: 10.1136/thoraxjnl-2018-211715] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Doolan CP, Louie T, Lata C, Larios OE, Stokes W, Kim J, Brown K, Beck P, Deardon R, Pillai DR. Latent class analysis for the diagnosis of Clostridioides difficile infection. Clin Infect Dis 2020:ciaa1553. [PMID: 33053174 DOI: 10.1093/cid/ciaa1553] [Reference Citation Analysis]
2 Menzies NA, Shrestha S, Parriott A, Marks SM, Hill AN, Dowdy DW, Shete PB, Cohen T, Salomon JA. The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease. Epidemiology 2022;33:75-83. [PMID: 34669631 DOI: 10.1097/EDE.0000000000001418] [Reference Citation Analysis]
3 Drain PK, Gardiner J, Hannah H, Broger T, Dheda K, Fielding K, Walzl G, Kaforou M, Kranzer K, Joosten SA, Gilpin C, Weyer K, Denkinger CM, Schumacher SG. Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis. J Infect Dis 2019;220:S108-15. [PMID: 31593598 DOI: 10.1093/infdis/jiz356] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
4 Adams S, Ehrlich R, Baatjies R, Dendukuri N, Wang Z, Dheda K. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting. Int J Environ Res Public Health 2019;16:E2912. [PMID: 31416206 DOI: 10.3390/ijerph16162912] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Haddad MB, Lash TL, Castro KG, Hill AN, Navin TR, Gandhi NR, Magee MJ. Tuberculosis Infection Among People With Diabetes: United States Population Differences by Race/Ethnicity. Am J Prev Med 2020;58:858-63. [PMID: 32061457 DOI: 10.1016/j.amepre.2019.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ma Y, Li R, Shen J, He L, Li Y, Zhang N, Wu Q, Zhang J, Zheng J, Wang X. Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis. BMC Infect Dis 2019;19:993. [PMID: 31752713 DOI: 10.1186/s12879-019-4597-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
7 Haddad MB, Lash TL, Hill AN, Navin TR, Castro KG, Gandhi NR, Winston CA. Robustness of NHANES Estimates of the US Prevalence of a Positive Tuberculin Skin Test. Epidemiology 2020;31:248-58. [PMID: 31764278 DOI: 10.1097/EDE.0000000000001141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Yelk Woodruff R, Hill A, Marks S, Navin T, Miramontes R. Estimated Latent Tuberculosis Infection Prevalence and Tuberculosis Reactivation Rates Among Non-U.S.-Born Residents in the United States, from the 2011-2012 National Health and Nutrition Examination Survey. J Immigr Minor Health 2021;23:806-12. [PMID: 32761297 DOI: 10.1007/s10903-020-01065-8] [Reference Citation Analysis]
9 Ho CS, Feng PI, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study. Lancet Infect Dis 2021:S1473-3099(21)00145-6. [PMID: 34499863 DOI: 10.1016/S1473-3099(21)00145-6] [Reference Citation Analysis]
10 Nolt D, Starke JR. Tuberculosis Infection in Children and Adolescents: Testing and Treatment. Pediatrics 2021;148:e2021054663. [PMID: 34851422 DOI: 10.1542/peds.2021-054663] [Reference Citation Analysis]
11 Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, Cohen T, Salomon JA. Time Since Infection and Risks of Future Disease for Individuals with Mycobacterium tuberculosis Infection in the United States. Epidemiology 2021;32:70-8. [PMID: 33009253 DOI: 10.1097/EDE.0000000000001271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
12 Stout JE, Turner NA, Belknap RW, Horsburgh CR, Sterling TR, Phillips PPJ. Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling. Am J Respir Crit Care Med 2020;201:598-605. [PMID: 31711306 DOI: 10.1164/rccm.201908-1606OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gatchalian SR, Agathis NT, Castillo-Carandang NT, Gunter SM, Murray KO, Mandalakas AM. Design and Evaluation of Risk Assessment Tools to Identify Pediatric Tuberculosis Infection in Bohol, the Philippines, a Low-HIV- and High-TB-Burden Setting. Am J Trop Med Hyg 2020;103:1818-26. [PMID: 32975174 DOI: 10.4269/ajtmh.20-0244] [Reference Citation Analysis]
14 Collins JM, Stout JE, Ayers T, Hill AN, Katz DJ, Ho CS, Blumberg HM, Winglee K; Tuberculosis Epidemiologic Studies Consortium. Prevalence of Latent Tuberculosis Infection among Non-U.S.-Born Persons by Country of Birth - United States, 2012-2017. Clin Infect Dis 2020:ciaa1662. [PMID: 33137172 DOI: 10.1093/cid/ciaa1662] [Reference Citation Analysis]
15 Che Y, Yang T, Lin L, Xiao Y, Jiang F, Chen Y, Chen T, Zhou J. Comparative Utility of Genetic Determinants of Drug Resistance and Phenotypic Drug Susceptibility Profiling in Predicting Clinical Outcomes in Patients With Multidrug-Resistant Mycobacterium tuberculosis. Front Public Health 2021;9:663974. [PMID: 33968888 DOI: 10.3389/fpubh.2021.663974] [Reference Citation Analysis]
16 Pettit AC, Stout JE, Belknap R, Benson CA, Séraphin MN, Lauzardo M, Horne DJ, Garfein RS, Maruri F, Ho CS; Tuberculosis Epidemiologic Studies Consortium (TBESC). Optimal Testing Choice and Diagnostic Strategies for Latent Tuberculosis Infection Among US-Born People Living with Human Immunodeficiency Virus (HIV). Clin Infect Dis 2021;73:e2278-84. [PMID: 32761083 DOI: 10.1093/cid/ciaa1135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]